Prior Government and Private Sector Support
The LINC Pharmaceuticals technology has been funded by more than $8
million in grants, with the majority of this money provided through the
National Institutes of Health. In addition to seeking funding from the
private sector, LINC will apply for federal funding through programs such
as the Small Business Innovation Research grants (SBIR) during the
startup phase of the company.
The academic development of the technology by the scientific founders
of LINC has been supported by $8.5 million from:
National Heart, Lung and Blood Institute at the NIH
March of Dimes
American Heart Association
Phillip Morris Foundation
Brigham and Women’s Hospital of Boston
Harvard University Medical School, Department of Pediatrics
University of Maryland Medical School, Department of Pediatrics
Harbor-UCLA Medical Center, Department of Pediatrics
Harbor-UCLA Research and Education Institute
|
